Hongying Liao
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
PHKG2 confers resistance of ESCC to cisplatin and enhances CXCL8-dependent immunosuppression to exacerbate tumorigenesis.
Journal: Cell death & disease
Published: September 15, 2025
APOC1 expressed in macrophages promotes the pulmonary metastasis of colorectal cancer via CCL2/CCL5.
APOC1 expressed in macrophages promotes the pulmonary metastasis of colorectal cancer via CCL2/CCL5.
Journal: International immunopharmacology
Published: December 20, 2024
Identification and validation of pyroptosis patterns with a novel quantification system for the prediction of prognosis in lung squamous cell carcinoma.
Journal: Translational lung cancer research
Published: October 25, 2024
Primary tumor resection might improve outcomes in metastatic thoracic esophageal cancer.
Journal: Scientific reports
Published: August 17, 2024
Survival benefit of metastasectomy in colorectal cancer with pulmonary metastasis: a population-based, propensity score matched study.
Journal: Gastroenterology report
Published: June 12, 2024
Role of the Forkhead box family protein FOXF2 in the progression of solid tumor: systematic review.
Journal: Journal of cancer research and clinical oncology
Published: April 08, 2024
Addition of bevacizumab to EGFR tyrosine kinase inhibitors in advanced NSCLC: an updated systematic review and meta-analysis.
Journal: Frontiers in pharmacology
Published: June 12, 2023
Correction: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. Cancers 2022, 14, 5344.
Journal: Cancers
Published: December 07, 2022
miR-183-5p regulates ECM and EMT to promote non-small cell lung cancer progression by targeting LOXL4.
Journal: Journal of thoracic disease
Published: November 29, 2022
Last Updated: 09/26/2026